Targeting IL-36 in Inflammatory Skin Diseases Ryo FukauraMasashi Akiyama Leading Article 03 March 2023 Pages: 279 - 293
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus Charl VerweyShabir A. Madhi Review Article Open access 25 April 2023 Pages: 295 - 309
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer Motahareh ArjomandnejadIshani DasguptaAllison M. Keeler Review Article Open access 02 March 2023 Pages: 311 - 329
Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus Mingshu HuangWeixing ChenBo Jia Review Article 13 May 2023 Pages: 331 - 352
Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery Amir Hossein MohammadiZeinab GhazvinianKaveh Baghaei Review Article 24 April 2023 Pages: 353 - 374
Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome) Valentina D. GusarovaMaxim A. SmolovRahim R. Shukurov Original Research Article 04 April 2023 Pages: 375 - 395
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System Hugo JourdainLéa HoisnardMahmoud Zureik Original Research Article Open access 06 March 2023 Pages: 397 - 407
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis Kuan PengJoseph E. BlaisXue Li Original Research Article Open access 23 March 2023 Pages: 409 - 420
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing Taihang ShaoMingye ZhaoWenxi Tang Original Research Article 25 February 2023 Pages: 421 - 432
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial Justin StebbingYauheni BaranauSunghyun Kim Short Communication Open access 07 March 2023 Pages: 433 - 440
Correction to: Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study Douglas J. RupertAlyssa M. JordanR. Craig Lefebvre Correction 07 March 2023 Pages: 441 - 441
